Literature DB >> 19631491

[Cocaine and alcohol: a risky association].

Jérôme Lacoste1, Manuela Pedrera-Melgire, Aimé Charles-Nicolas, Nicolas Ballon.   

Abstract

Key points. Cocaine, the second most frequently consumed illicit substance after cannabis in both United States and Europe, remains the psychostimulant of choice for many, often mixed with other psychoactive substances. It is most frequently associated with alcohol, and a diagnosis of alcohol dependence may be made in 50%-90% of cocaine-dependent subjects. When treating cocaine addicts, it is important to characterize not only the modalities of cocaine use but also the modes of consumption of other substances, notably alcohol. Alcohol is often consumed to reduce the anxiety and discomfort resulting from cocaine withdrawal. Alcohol may also trigger an irresistible craving for cocaine, which can result in frequent relapses even after several months of cocaine abstinence. Brief intervention and motivational interview techniques can help to reduce alcohol use and prevent cocaine relapses in this context. In the absence of severe cocaine withdrawal symptoms, the guidelines for treating alcohol withdrawal syndrome may be applied for cocaine and alcohol codependence. Lower doses of benzodiazepine are needed for treating this alcohol-cocaine withdrawal syndrome. Cognitive behavioral therapies, alone or in combination with psychotropic medication, are accepted therapeutic approaches for alcohol-cocaine dependence. It is also accepted that over the long term the combination of psychotherapeutic treatments is usually more effective than any single approach. In the absence of a therapeutic consensus, four drugs (disulfiram, baclofen, topiramate and naltrexone) are most often recommended to promote and maintain abstinence; nevertheless, their efficacy has not been proven and their use remains experimental and off-label: they have not been approved by health authorities as treatment for addictions. Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19631491     DOI: 10.1016/j.lpm.2009.05.011

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

1.  Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood.

Authors:  Javier Calleja-Conde; Victor Echeverry-Alzate; Elena Giné; Kora-Mareen Bühler; Roser Nadal; Rafael Maldonado; Fernando Rodríguez de Fonseca; Antoni Gual; Jose Antonio López-Moreno
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

2.  Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians.

Authors:  Christopher S Tallarida; Kristopher Bires; Jacob Avershal; Ronald J Tallarida; Stephanie Seo; Scott M Rawls
Journal:  Alcohol       Date:  2014-08-07       Impact factor: 2.405

3.  Alcohol-related brief intervention in patients treated for opiate or cocaine dependence: a randomized controlled study.

Authors:  Nelson Feldman; Anne Chatton; Riaz Khan; Yasser Khazaal; Daniele Zullino
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-17

4.  Static posturography in addicted to illicit drugs and alcohol.

Authors:  Daniela Affonso Moreira; Maurício Malavasi Ganança; Heloisa Helena Caovilla
Journal:  Braz J Otorhinolaryngol       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.